Trailing Twelve Months Revenue Growth: Inhibrx Corp (INBX)

Public company logo of inhibrx.com (INBX)

The GURU.Markets terminal line chart, illustrating the year-over-year sales volume growth over the last 12 months, recorded a figure of 43.10. Inhibrx Biosciences (INBX) generates revenue based on royalties and payments from Sanofi for the drug INBRX-101. The company minimizes risks by developing protein-based therapies for cancer and rare pathologies, while enhancing drug discovery efficiency through the implementation of robotic screening systems.

Inhibrx Biosciences (INBX): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Inhibrx Biosciences - analytical breakdowns and key metrics (INBX)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Inhibrx Biosciences Inc
Brand item of Inhibrx Corp

This indicator measures operational efficiency by recalculating annual revenue growth over a rolling period, allowing for an assessment of business scaling rates and asset stagnation risks. Since Inhibrx Biosciences (INBX) focuses on early-stage antibody development and lacks commercial sales, the comparative rolling year-over-year sales dynamics merely reflect the absence of current cash flow prior to the completion of clinical trials.

Who Inhibrx Biosciences competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) IMAB|Trailing Twelve Months Revenue Growth Fennec Pharmaceuticals FENC|Revenue Growth YoY (Last 12 Months) HRTX (Heron)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)